Bioethics News

Genetic Test to Predict Opioid Risk Lacks Proof, Experts Say

February 7, 2017

(Philadelphia Inquirer) – It sounds like a godsend for America’s opioid epidemic: genetic tests that can predict how a patient will respond to narcotic painkillers, as well as an individual’s risk of misuse, addiction, and potentially deadly side effects. Proove Biosciences of Irvine, Calif., claims its “opioid response” and “opioid risk” tests are the only precision medicine tools on the market to do all that, giving doctors information “to guide opioid selection and dosage decisions as well as treat side effects.”

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.